Search Results - "Rocío Tamayo-Bermejo"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Conciliación de la medicación al ingreso en el servicio de Cirugía Ortopédica y Traumatológica by Laila Dani Ben Abdel-Lah, Rocío Tamayo-Bermejo, María Rosa Cantudo-Cuenca

    Published in Ars Pharmaceutica (01-03-2021)
    “…Resumen Introducción: Identificar las discrepancias existentes entre la medicación prescrita al ingreso en el servicio de traumatología y la medicación…”
    Get full text
    Journal Article
  2. 2

    Effectiveness and safety of pembrolizumab monotherapy in patients with locally advanced or metastatic non-small-cell lung cancer by Tamayo-Bermejo, Rocio, del Rio-Valencia, Juan Carlos, Mora-Rodriguez, Beatriz, Muñoz-Castillo, Isabel

    Published in Journal of oncology pharmacy practice (01-01-2023)
    “…Introduction Immunotherapy has become a standard treatment for lung cancer; the objective of this study was to evaluate the effectiveness, safety of…”
    Get full text
    Journal Article
  3. 3

    Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results by Fernández-Cuerva, Cristina, Valencia, Juan Carlos Del Rio, Bermejo, Rocio Tamayo

    Published in Canadian journal of hospital pharmacy (01-01-2022)
    “…Real-world data are critical to demonstrate the reproducibility of evidence and the external generalizability of randomized clinical trials. Palbociclib is an…”
    Get full text
    Journal Article
  4. 4

    Effectiveness of 12 week ledipasvir/sofosbuvir and predictors of treatment failure in patients with hepatitis C by Del Rio-Valencia, J C, Asensi-Diez, R, Tamayo-Bermejo, R, Muñoz-Castillo, I

    Published in Revista española de quimioterapia (01-08-2019)
    “…The efficacy of ledipasvir/sofosbuvir (LDV/SOF) have been demonstrated in randomized controlled trials, however,there is an unmet need for real-world…”
    Get full text
    Journal Article
  5. 5

    Application of Pharmacokinetics Programs in Optimization of Haemostatic Treatment in Severe Hemophilia a Patients: Changes in Consumption, Clinical Outcomes and Quality of Life by Mingot-Castellano, María Eva, Díaz-Canales, Dana, Tamayo-Bermejo, Rocio, Heiniger-Mazo, Ana Isabel

    Published in Blood (06-12-2014)
    “…Replacement therapy with factor VIII (FVIII) in patients with severe hemophilia A has a high cost. To optimize this consumption without an increase in bleeding…”
    Get full text
    Journal Article
  6. 6

    Indication, Resource Consumption and Clinical Outcomes of Prophylaxis in Adult Patients with Severe Hemophilia a in Routine Clinical Practice by Mingot-Castellano, María Eva, González-Díaz, Laura, Tamayo-Bermejo, Rocio, Heiniger-Mazo, Ana Isabel

    Published in Blood (06-12-2014)
    “…Background: Prophylaxis is the treatment of choice in patients with severe hemophilia A to prevent the development of haemophilic arthropathy and to preserve…”
    Get full text
    Journal Article
  7. 7

    Adult severe haemophilia A patients under long-term prophylaxis with factor VIII in routine clinical practice by Mingot-Castellano, María E, González-Díaz, Laura, Tamayo-Bermejo, Rocio, Heiniger-Mazo, Anabel I

    Published in Blood coagulation & fibrinolysis (01-07-2015)
    “…There is no clear consensus on the best practice for long-term prophylaxis in adults with severe haemophilia A. This is a single-centre prospective case series…”
    Get full text
    Journal Article
  8. 8